Maxim Group analyst Jason McCarthy downgrades 9 Meters Biopharma (NASDAQ:NMTR) from Buy to Hold.
Connect Biopharma To Host A Conference Call Tuesday, October 4 To Discuss Topline Results For The Pivotal Trial In China Of Lead Candidate, CBP-201, In Patients With Moderate-To-Severe Atopic Dermatitis
Conference call and webcast to take place at 5:30 a.m. PDT/8:30 a.m. EDT,
tomorrow, Tuesday, October 4
SAN DIEGO and TAICANG, SUZHOU, China, Oct. 03, 2022 (GLOBE NEWSWIRE) -- Connect Biopharma Holdings Limited